Originally published In Press as doi:10.1074/jbc.M200288200 on February 4, 2002
J. Biol. Chem., Vol. 277, Issue 16, 13578-13582, April 19, 2002
Intracellular Coupling of the Heavy Chain of Pre-
-inhibitor to
Chondroitin Sulfate*
Aneta
Kaczmarczyk
,
Maria
Thuveson, and
Erik
Fries
From the Department of Medical Biochemistry and Microbiology,
Uppsala University, Biomedical Center, S-751 23, Uppsala,
Sweden
Received for publication, January 10, 2002, and in revised form, January 30, 2002
 |
ABSTRACT |
Pre-
-inhibitor is a serum protein consisting
of two polypeptides, the heavy chain and bikunin, covalently linked
through an ester bond between the chondroitin sulfate chain of bikunin and the
-carboxyl group of the carboxyl-terminal residue of the heavy chain. The heavy chain is synthesized with a
carboxyl-terminal extension, which is cleaved off just before the link
to bikunin is formed. Our earlier studies indicate that this extension
mediates the cleavage, and we have now found that a short segment on
the amino-terminal side of the cleavage site is also required for the
reaction. Furthermore, we previously showed that coexpression of the
heavy chain precursor and bikunin in COS-1 cells leads to linkage, and
we have now used this system to identify a His residue in the
carboxyl-terminal extension that is specifically required for the
intracellular coupling of the two proteins. In addition, we have shown
that another chondroitin sulfate-containing protein, decorin, will also
form a complex with the heavy chain, as will free chondroitin sulfate
chains. These results suggest that in vivo there
might be other, as yet unknown, chondroitin sulfate-containing
polypeptides linked to the heavy chain.
 |
INTRODUCTION |
Bikunin
(Bk)1 is a 25-kDa chondroitin
sulfate-containing protein consisting of two Kunitz-type protease
inhibitor domains, which is secreted by hepatocytes (reviewed in Ref.
1). The physiological function of bikunin is unknown, but recent
in vitro studies suggest that it might play a role in
inflammatory reactions (2, 3). In blood plasma, most Bk occurs in
complex with one or two polypeptides of 75-80 kDa named the heavy
chains, which are homologous to each other. The corresponding proteins
are pre-
-inhibitor (P
I) bikunin linked with heavy chain 3 and
inter-
-inhibitor bikunin linked with heavy chains 1 and 2 (4). These
proteins have been shown to be required for the stabilization of the
cumulus cell-oocyte complex (5), as well as for the formation of the hyaluronan-containing coat on fibroblasts and mesothelial cells (6). In
inflamed tissues (2) and in cell cultures of fibroblasts (7), the heavy
chains have been found to be transferred to hyaluronan molecules. The
physiological significance of this process is not known, but in
vitro experiments have shown that hyaluronan molecules bearing
heavy chains are less sensitive to degradation by free radicals
(8).
Bikunin is synthesized in a precursor form that has
1-microglobulin at its amino terminus (9, 10), and the
two proteins are released through a proteolytic cleavage late in the
Golgi complex (11, 12). The heavy chains are synthesized with a carboxyl-terminal extension (CTX), which is cleaved off when the proteins reach the Golgi complex (13, 14). Both bikunin and the heavy
chains are synthesized in hepatocytes, and immediately after the
cleavage of the CTX, they become linked through an ester bond between
the chondroitin sulfate chain of bikunin and the
-carboxyl group of
the carboxyl-terminal amino acid residue of the heavy chains (4, 15)
(Fig. 1). The molecular mechanism of this assembly process is still
poorly known. We have previously shown, however, that coexpression of
the precursors of bikunin and the heavy chain of P
I (heavy chain 3:
H3) in COS-1 cells leads to coupling (16), and we have used this system
to investigate both the cleavage and coupling reactions. These studies
provided evidence that the CTX cleavage occurs through an
intramolecular reaction (17, 18).
In the present study we have investigated whether the part of the heavy
chain precursor corresponding to mature H3 has a role in CTX cleavage.
Our results show that an 8-amino acid residue segment preceding the
cleavage site is necessary and sufficient for this reaction. We have
also identified a His residue (His646) in the CTX that is
essential for the coupling of H3 to the bikunin precursor (but not for
CTX cleavage). In addition, we have found that the
1-microglobulin part of the bikunin precursor is not essential for the coupling and that H3 can be linked to the chondroitin sulfate of a proteoglycan other than bikunin, as well as to free chondroitin sulfate chains. Because bikunin is the most abundant CS-containing proteoglycan produced by hepatocytes and so far the only
protein known to be covalently linked to the heavy chains, our results
suggest that there might be other, minor chondroitin sulfate-containing
proteins linked to heavy chains in vivo.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Tissue culture media, fetal bovine serum, and
glutamine were obtained from Statens Veterinärmedicinska Anstalt
(Uppsala, Sweden) and pXM and pSecTag plasmids from The Genetics
Institute, Inc. (Cambridge, MA) and Invitrogen (Leek, The Netherlands),
respectively. Oligonucleotides were from DNA Technology (Aarhus,
Denmark), Tran35S label (>1000 Ci/mmol) and
[35S]sulfate from ICN (Costa Mesa, CA), and
chondroitinase ABC,
p-nitrophenyl-
-D-xylopyranoside (pNPXP), and
proteinase inhibitor mixture (C3667) were from Sigma. P
I was
purified from rat plasma as previously described (16), and antiserum
was produced in a rabbit. Antiserum against rat serum albumin was
produced in a rabbit. Rabbit antiserum to rat decorin was a gift from
Dr. Å. Oldberg, Lund University, Sweden.
Construction of Expression Vectors--
cDNA for mouse
albumin was obtained by PCR from mouse liver cDNA (Marathon-Ready,
CLONTECH). The primers used were:
5'-ACTACGTCGACATGAAGTGGGTAACCTTTCTCCTCCTC-3' (forward) and
5'-ACTCTGAATTCTTAGGCTAAGGCGATCTTTGCATCTAG-3'(reverse). cDNA for
carboxyl-terminal fragments of heavy chain 3 precursor (pH3) starting
at positions corresponding to amino acids 522, 633, 634, 636, 638, 639, 640, or 644 were obtained by PCR and cloned in-frame with cDNA for
albumin at SalI restriction sites. The SalI site
inserting two amino acid residues (Val-Asp) at the linkage region of
each construct was introduced by PCR at the 3' and 5' ends of the
albumin and pH3 fragments, respectively. The fusion constructs
described above, as well as the cDNAs coding for rat pH3 (16) and
human decorin (a gift from Dr. Å. Oldberg, Lund University, Sweden),
were cloned into the eukaryotic expression vector pXM. The
bikunin coding sequence was amplified by PCR using rat
1-microglobulin-bikunin cDNA (a gift from B. Åkerström, Lund University, Sweden) and subcloned into the
pSecTagB expression vector in-frame with an Ig
-chain signal
sequence. Substitutions of amino acid residues were made with the
unique site elimination procedure (U.S.E. mutagenesis kit, Amersham
Biosciences AB, Sweden). All constructions were verified by DNA sequencing.
Transfection and Metabolic Labeling--
COS-1 cells were
transfected by electroporation as described previously (16). Two days
later, the cells were rinsed twice with phosphate-buffered saline and
metabolically labeled in the presence of either
[35S]methionine or
35SO
. For protein
labeling, the cell cultures were incubated in 1.0 ml of Eagle's
minimal essential medium supplemented with 2 µM
methionine, 2 mM glutamine, and [35S]methionine (0.1 mCi/ml) for 4 h at 37 °C.
For labeling of sulfated polysaccharides, 1.0 ml of Eagle's minimal
essential medium lacking SO
and
supplemented with 2 mM glutamine, 1 mg/ml bovine serum
albumin, and 35SO
(0.1 mCi/ml) was used, and the cells were incubated for 4 h at
37 °C.
Immunoprecipitation--
The medium of labeled cells was
subjected to immunoprecipitation, and subsequent electrophoretic
analysis was done as previously described (16), except that the
radioactivity detection was done by phosphorimaging (Bio-Imaging
Analyzer, Fujifilm).
Induction of Free Chondroitin Sulfate Synthesis--
COS-1 cells
transfected with pH3 were incubated at 37 °C with various
concentrations of pNPXP or with vehicle alone (3% Me2SO) in 1.0 ml of labeling medium. After 30 min, either
[35S]methionine or
35SO
(0.1 mCi) was added
to the cultures, and the incubation was continued for 4 h.
Chondroitinase Treatment--
The immunoprecipitates were
resuspended in 30 µl of 50 mM Tris-HCl, pH 8.0, supplemented with a protease inhibitor mixture (to the final
concentration of 26 mM 4-(2-aminoethyl)-benzenesulfonyl fluoride, 20 µM aprotinin, 0.53 mM leupeptin,
0.90 mM bestatin, 0.38 mM pepstatin A, and 0.35 mM E-64) and then incubated with or without 5 milliunits of
chondroitinase ABC for 5 h at 37 °C. Subsequently, the samples
were subjected to SDS-PAGE, and radioactivity was detected by phosphorimaging.
 |
RESULTS |
Structural Requirements for Cleavage of the
Carboxyl-terminal Extension of H3--
During the secretory transport
of the pH3 in hepatocytes, the CTX is cleaved off (Fig.
1). This reaction also occurs, although at a lower efficiency (40-60%), when pH3 is expressed in COS-1 cells.
Based on results obtained in this system after the introduction of
various mutations, we earlier concluded that the CTX, as well as a few
adjacent amino acid residues on the amino-terminal side of the cleavage
site, play a crucial role in the cleavage process (17). In the present
study we wanted to determine whether other regions of the precursor are
also engaged in this reaction. Therefore, amino-terminal segments of
different length were deleted, and the remaining polypeptides preceded
by the native signal peptide were expressed in COS-1 cells. Analysis of
the culture medium showed, however, that these truncated forms were
poorly secreted, presumably because of misfolding (data not shown). To
circumvent this problem, we instead fused the amino termini of the
truncated pH3s to the carboxyl terminus of albumin (Fig.
2A; the positions of fusion
are indicated with open triangles). For all albumin-pH3 chimeras in which up to 639 amino-terminal residues of pH3 were deleted, the level of cleavage was similar to that of wild type (40-60%) (Fig. 2B, lane 1). For a chimeric
protein fused at amino acid position 641, however, the degree of
processing was significantly lower (5-15%), and one containing pH3
that lacked 643 amino-terminal residues displayed no cleavage (Fig.
2B, lane 2). Fig. 2A summarizes the extent of cleavage of CTX for the different constructs and shows
that cleavage requires a segment of the mature heavy chain that is
about 8 amino acid residues long.

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 1.
Biosynthesis of
pre- -inhibitor. Heavy chain 3 and bikunin
(both in black) are synthesized as precursors with carboxyl-
and amino-terminal extensions, respectively (in white). As
the bikunin precursor reaches the Golgi complex, it acquires a
chondroitin sulfate chain (CS). In the same organelle, the
heavy chain precursor is cleaved, and the new carboxyl terminus becomes
linked to the chondroitin sulfate chain; the released carboxyl-terminal
extension appears to mediate this reaction. Finally, the extension of
the bikunin precursor ( 1-microglobulin) is released, and
pre- -inhibitor is formed. The figure was adapted from Ref.
17.
|
|

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 2.
A short segment on the amino-terminal side of
the cleavage site is required for intracellular cleavage of the H3
precursor. A, the H3 precursor, consisting of mature H3
(in black) and the CTX (in white; compare Fig.
1), was truncated from its amino terminus at different sites, and the
remaining carboxyl-terminal fragments were fused to the carboxyl
terminus of albumin (hatched rectangle; VD shows
the Val-Asp residues derived from a SalI restriction site
and present in all constructs). The amino acid sequence around the
cleavage site between H3 and the CTX (closed arrow head) is
shown with the different fusion sites as open arrow heads
and the amino acid residues conserved between four species in
bold. The albumin-pH3 chimeras were then expressed in COS-1
cells, and cleavage was assessed as described below. The results are
shown below the respective fusion site: chimeras yielding more than
40% cleavage are indicated with (+), those with 5-15% cleavage or
completely resistant with (±) or ( ), respectively. B,
COS-1 cells were transiently transfected with pXM containing wild type
pH3 (lane 3, wt) or fusions of albumin with the pH3
fragments remaining after the deletion of 639 ( 639,
lane 1) or 643 ( 643, lane 2)
amino-terminal amino acid residues. The cells were then labeled with
[35S]methionine for 4 h. The culture media were
immunoprecipitated with antibodies against albumin or P I as
indicated below the lanes and analyzed by SDS-PAGE followed by
phosphorimaging. The upper and lower bands correspond to the uncleaved
protein and the protein lacking the CTX, respectively. Note the lack of
cleavage in lane 2. The positions of standard proteins run
in parallel are shown to the right with their molecular
masses in kDa.
|
|
His649 in CTX Is Essential for Coupling of H3 to
Bikunin--
We have earlier identified amino acid residues near the
cleavage site of rat pH3 that are crucial for the cleavage process (17). In the present investigation, we wanted to determine whether the
conserved amino acid residues in this region that were found to have
little or no influence on cleavage are instead essential for the
subsequent coupling to the bikunin precursor. We therefore coexpressed
bikunin and mutated H3 precursors in COS-1 cells and then assessed
coupling by electrophoretic analysis of the secreted proteins as
earlier described (17). pH3 mutated at Phe650 or at
Ile651+652 seemed to yield the same degree of complex
formation as that obtained with the wild type protein (Fig.
3, lanes 3 and 4,
compare with lane 1; the arrow indicates the
complex consisting of H3 and bikunin precursor). On the contrary, a
His649 mutant (which displayed reduced CTX cleavage) did
not show any detectable coupling (lane 2). Thus,
His649 seems to be specifically required for the coupling
reaction. Mutation of Gly789 abolishes cleavage of
the CTX (17) and, as expected, coexpression of this mutant with the
bikunin precursor did not result in the formation of any complex
(lane 5).

View larger version (67K):
[in this window]
[in a new window]
|
Fig. 3.
His649 in the carboxyl-terminal
extension of H3 is required for coupling to the bikunin precursor.
Mutations were introduced at specific sites in the carboxyl-terminal
extension of H3 as indicated above the lanes, and the corresponding
proteins were coexpressed with the bikunin precursor in COS-1 cells.
The cells were then labeled with [35S]methionine for
4 h, and the culture media were analyzed by immunoprecipitation
with antibodies against P I, followed by SDS-PAGE and
phosphorimaging. The complex formed between the bikunin precursor and
H3 is indicated with an arrow. pH3, H3 precursor;
H3, mature H3; Bk+CS, bikunin precursor with
chondroitin sulfate; Bk CS, bikunin precursor without
chondroitin sulfate. Note the absence of the complex in lanes
2 and 5. For the H3 mutant in lane 4,
Ile651 and Ile652 were both changed to Val. The
positions of standard proteins are shown to the right with
their molecular masses in kDa.
|
|
Structural Requirement in Bikunin Precursor for Coupling--
The
reason why bikunin is synthesized as a precursor is not known.
1-microglobulin is released after coupling of the
precursor to the heavy chain has occurred and could therefore be
necessary for the coupling process. To test this possibility, we
expressed in COS-1 cells the precursor from which the
1-microglobulin moiety had been deleted. Analysis of the
secreted proteins with bikunin antiserum revealed a broad band with the
same apparent molecular mass as that of authentic bikunin (~40 kDa;
Fig. 4, lane 1, Bk+CS). When this truncated bikunin precursor was
coexpressed with pH3, a complex with an apparent mass of 120-200 kDa
was formed (lane 3, square bracket-asterisk).
Treatment with chondroitinase ABC (lane 4) resulted in its
disappearance and the release of proteins with the electrophoretic
mobilities of H3 and of bikunin without the polysaccharide
(Bk
CS; the double band results from differences in
N-linked glycosylation, see Ref. 11). Thus, it appears that bikunin is able to form a chondroitin sulfate-linked complex with H3 in
the absence of the
1-microglobulin part of the
precursor.

View larger version (72K):
[in this window]
[in a new window]
|
Fig. 4.
The
1-microglobulin moiety of the bikunin
precursor is not required for coupling to H3. COS-1 cells were
transfected with either pSecTagB containing the bikunin precursor from
which the 1-microglobulin sequence was deleted
(Bk, lane 1) or heavy chain precursor in pXM
(pH3, lanes 2 and 5), or they were
cotransfected with Bk and pH3 (lanes 3 and 4).
The cells were then labeled with [35S]methionine for
4 h, and the culture media were analyzed by immunoprecipitation
with bikunin antiserum followed by SDS-PAGE and phosphorimaging. The
square bracket-asterisk indicates the complex formed between
Bk and H3. The presence of chondroitin sulfate in the complex was
assessed with chondroitinase ABC treatment of the immune complexes
(ABC, samples incubated with or without the enzyme indicated
with + or , respectively). Note the appearance of H3 and
of bikunin without chondroitin sulfate in lane 4 (Bk CS). For comparison, the medium from cells expressing
pH3 alone and assayed with P I antibodies is also shown (lane
5). The positions of standard proteins are shown to the
right with their molecular masses in kDa.
|
|
Coupling of H3 to Decorin--
We then wanted to examine whether
the polypeptide part of bikunin is needed for coupling to H3. For this
purpose we used another chondroitin sulfate-containing protein,
decorin, which is synthesized by most types of connective tissue and
consists of a 45-kDa core polypeptide chain and a chondroitin/dermatan
sulfate chain of variable size (19). Expression of decorin in COS-1
cells and immunoprecipitation of the secreted proteins with antiserum
against decorin yielded a diffuse band of 50-90 kDa (Fig.
5, lane 2, Dec+CS/DS) and a more distinct band of 45 kDa
(Dec
CS/DS). These bands most likely represent decorin with
or without chondroitin/dermatan sulfate, respectively, because only the
slowly migrating band was sensitive to treatment with chondroitinase
ABC (lane 3). When decorin was coexpresssed with pH3, a
150-200-kDa complex was detected in the cell culture medium by
immunoprecipitation with either decorin or pre-
-inhibitor antisera
(lanes 4 and 6, respectively, square
bracket-asterisk). Chondroitinase ABC treatment of the immune
complexes obtained with decorin antiserum resulted in the disappearance
of the complex and generated a band with the electrophoretic mobility
of H3 (lane 5, arrow, compared with lane
8). When pre-
-inhibitor antibodies were used for the
immunoprecipitation, subsequent chondroitinase ABC treatment resulted
in the formation of a new band with the mobility of decorin lacking
glycosaminoglycan (lane 7, arrow, compared with
lane 3). Taken together, these results indicate that upon
coexpression of pH3 and decorin, the two proteins form a complex linked
by a chondroitin sulfate chain.

View larger version (59K):
[in this window]
[in a new window]
|
Fig. 5.
Coexpression of decorin and H3 results in
coupling. COS-1 cells were transfected with pXM containing either
pH3 or decorin (Dec) or were cotransfected with
both plasmids as indicated above the lanes. After labeling with
[35S]methionine, the secreted proteins were analyzed by
immunoprecipitation with decorin (lanes 1-5) or P I
(lanes 6 and 7) antiserum, followed by SDS-PAGE
and phosphorimaging. The square bracket-asterisk
indicates the high molecular weight complex formed upon coexpression of
pH3 and decorin. Sensitivity to chondroitinase ABC (ABC) was
assessed by incubation of the immune complexes before electrophoresis
with (lanes 3, 5, and 7) or without
the enzyme (lanes 2, 4, and 6). Note
the appearance of bands with the electrophoretic mobility of H3
(lane 5) and of decorin without glycosaminoglycan
(lane 7), both indicated with an arrow.
Dec+CS/DS and Dec CS/DS denote decorin precursor
with and without glycosaminoglycan, respectively, and pH3
and H3, H3 precursor and mature H3, respectively. Positions
of molecular mass standards (in kDa) run in parallel are indicated to
the right.
|
|
Coupling of H3 to Free Chondroitin Sulfate--
The finding that
the polypeptide part of bikunin is not essential for the formation of
the H3-glycosaminoglycan linkage prompted us to ascertain whether H3
could be coupled to free chondroitin sulfate chains. It has previously
been demonstrated that such polysaccharides are synthesized and
secreted upon incubation of cells with certain xylosides, such as pNPXP
(20). Thus, we labeled COS-1 cells expressing H3 precursor with
[35S]methionine in the presence of increasing
concentrations of pNPXP. Analysis of the culture medium with P
I
antiserum revealed the formation of complexes larger than mature H3 and
of a broad range of sizes (Fig.
6A, square bracket,
lanes denoted (
)). Furthermore, the amount of H3 decreased
with increasing concentration of pNPXP. Treatment of the
immunoprecipitates with chondroitinase ABC (lanes denoted
(+)) resulted in the disappearance of the polydisperse molecules and a
concurrent increase in the amount of free H3. To confirm the presence
of chondroitin sulfate in the complexes formed, we incubated cells
expressing H3 precursor with pNPXP and
35SO
; under the
conditions used, mainly sulfated glycosaminoglycans were labeled.
Analysis of the culture medium with antiserum against P
I showed the
formation of H3-containing complexes with apparent molecular masses
higher than 200 kDa at a pNPXP concentration of 3.1 µM
(Fig. 6B, lane 3). At higher xyloside concentrations, complexes of lower molecular masses (90-120 kDa) were
more abundant. Treatment of the immune complexes with
chondroitinase ABC led to the disappearance of the H3-containing high
molecular mass material. Taken together, these results indicate that
the H3-containing complexes secreted upon expression of pH3 in the presence of pNPXP were H3 molecules linked to free chondroitin sulfate
chains of variable length.

View larger version (61K):
[in this window]
[in a new window]
|
Fig. 6.
H3 is coupled to free chondroitin sulfate
chains. COS-1 cells transfected with pXM containing the H3
precursor were induced to secrete free chondroitin sulfate chains (2 days after transfection) by the addition of pNPXP (concentration as
indicated above the lanes; 0, vehicle only) and
metabolically labeled with either [35S]methionine
(A) or [35S]sulfate (B). After
immunoprecipitation of the culture media with P I antiserum, the
samples were divided in half, and one part was treated with
chondroitinase ABC (ABC, +) and the other incubated without
the enzyme ( ). Finally, the samples were analyzed by
SDS-PAGE followed by phosphorimaging. The H3-containing complexes are
indicated with square brackets. Note the
dose-dependent reduction of the intensity of the H3 band
and the increase on enzyme treatment in A. Samples from
mock-transfected COS-1 cells treated with 3.2 mM pNPXP are
indicated as mock. pH3, heavy chain 3 precursor;
H3, mature heavy chain 3. Positions of molecular mass
standards (in kDa) run in parallel are indicated to the right.
|
|
 |
DISCUSSION |
The most important finding of this study has been that the
intracellular coupling of H3 to chondroitin sulfate does not depend on
the polypeptide bearing the polysaccharide. In fact, we found that H3
could be coupled to free chondroitin sulfate chains (Fig. 6). Although
our results were obtained through transfection experiments, they raise
the possibility that chondroitin sulfate-bearing proteins other than
bikunin might become linked to H3 in vivo. H3 has so far
been shown to be synthesized only by hepatocytes (21, 22). In these
cells, bikunin is by far the most abundant chondroitin sulfate-containing protein (11, 23), which could explain why only this
protein has been found to be linked to H3. Perhaps more sensitive
detection techniques would reveal that hepatocytes secrete other heavy
chain-linked proteins. As judged by in situ hybridization experiments, low levels of pH3 transcript are present in certain non-hepatic organs such as the brain (21). It remains to be seen
whether the corresponding protein is indeed produced in these tissues
and if so, in what form.
Based on results obtained with pH3 expressed in COS-1 cells, we
previously concluded that the intracellular cleavage of the carboxyl-terminal extension of pH3 is triggered by the low pH in the
trans Golgi and occurs through an autocatalytic
intramolecular reaction (18). Furthermore, we found that various
recombinant modifications of the CTX abolished cleavage, indicating
that this part of the protein is essential for the reaction (17).
Whether the remainder of the protein is also involved in the cleavage process was not investigated. To address this issue, we have in the
present investigation expressed chimeric proteins consisting of albumin
and carboxyl-terminal fragments of pH3 of various lengths (Fig.
2B). Albumin folds quickly into a globular structure (24) with a flexible carboxyl-terminal end (25), making it likely that in
the chimeric proteins, albumin and the pH3 fragments formed separate
domains with their functional properties preserved. Support for this
assumption comes from the observation that cleavage of the CTX in these
constructs was sensitive to a lowering of pH, similar to the wild type
protein (results not shown). Analysis of the different chimeric
proteins showed that cleavage, in addition to the CTX, required a short
(about 8 amino acid residues long) segment on the amino-terminal side
of the cleavage site (Fig. 2A). Interestingly, the
corresponding residues (Fig. 2A, in bold) are
conserved between the H3s of four different species (rat, mouse,
hamster, and man), suggesting that this region of H3 may be involved in
specific interactions or have a specific conformation necessary for
efficient cleavage.
Expression of pH3 in different cell lines has shown that the capacity
to cleave the protein varies between
cells,2 possibly because of
differences in the pH of their trans Golgi (18). Should it
be established that certain non-hepatic cells do secrete free pH3
in vivo, it is tempting to speculate that this form of the
protein may have a different function than that of P
I. The
autocatalytic cleavage might then serve as an activation step occurring
either intracellularly, as indicated by our experiments, or
extracellularly, where inflammation could lower the pH (26).
It was recently reported that the blood of mice lacking bikunin
contains only the proform of the heavy chains (5). Whether the absence
of the cleaved form is due to lack of autocatalytic cleavage in
hepatocytes or to rapid plasma clearance remains to be investigated.
Although the pH-dependent cleavage of pH3 appears to be
autocatalytic, it is possible that cleavage associated with coupling to
chondroitin sulfate occurs by a non-autocatalytic process requiring the
presence of the polysaccharide. Studies with heavy chain 1 and 2 support this view (14, 28).
We reported earlier that if the CTX is deleted from pH3, no coupling
takes place upon coexpression with bikunin (17). Because this
modification was relatively large and likely to cause a conformational change in the remaining polypeptide, the obtained result cannot simply
be taken as evidence that the CTX mediates coupling. In the present
study we found, however, that the mutation of a single amino acid
residue in the CTX (His646Gln) completely abolished coupling (Fig. 3).
These findings suggest a specific role of His649 in the
coupling process. Because chondroitin sulfate and His residues will
have opposite charges at the pH occurring in the Golgi complex, it is
possible that His649 might contribute to the initial
interaction with the glycosaminoglycan preceding its covalent linkage
to the heavy chain. Further evidence that the CTX has a central role in
the coupling reaction comes from the observation that coexpression of
bikunin and a chimeric protein consisting of albumin, 8 carboxyl-terminal residues of the mature H3, and CTX led to coupling
3; thus, the major part of
the mature H3 molecule does not seem to be involved in this process.
The mechanism of the coupling reaction is still unknown. Analysis of
the sequence of CTX has revealed some similarity with
multicopper-oxidases, but the significance of this finding is unclear
(27). Our attempts to achieve coupling by incubating secreted bikunin
and pH3 have so far been unsuccessful, possibly because as yet
unidentified auxiliary factors are required.
 |
ACKNOWLEDGEMENTS |
We thank Örjan Zetterqvist, Amos M. Sakwe, and Robert Kisilevsky for critical comments on the manuscript.
 |
FOOTNOTES |
*
This work was supported by grants from the Swedish Research
Council, the Erik, Karin, and Gösta Selander's Foundation, and Polysackaridforskning AB, Uppsala, Sweden.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Box 582, S-751 23 Uppsala, Sweden. Tel.: 46-18-471-43-50; Fax: 46-18-471-42-09; E-mail:
Aneta.Kaczmarczyk@imbim.uu.se.
Published, JBC Papers in Press, February 4, 2002, DOI 10.1074/jbc.M200288200
2
T. Bobrzy
ski and E. Fries, unpublished observations.
3
A. Kaczmarczyk and E. Fries, unpublished observations.
 |
ABBREVIATIONS |
The abbreviations used are:
Bk, bikunin;
P
I, pre-
-inhibitor;
H3, heavy chain 3;
pH3, heavy chain 3 precursor;
CTX, carboxyl-terminal extension of heavy chain 3;
CS, chondroitin
sulfate;
DS, dermatan sulfate;
pNPXP, p-nitrophenyl-
-D-xylopyranoside.
 |
REFERENCES |
| 1.
|
Fries, E.,
and Blom, A. M.
(2000)
Int. J. Biochem. Cell Biol.
32,
125-137[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Zhao, M.,
Yoneda, M.,
Okashi, Y.,
Kurono, S.,
Iwata, H.,
Ohnuki, Y.,
and Kimata, K.
(1995)
J. Biol. Chem.
270,
26657-26663[Abstract/Free Full Text]
|
| 3.
|
Wisniewski, H.,
Hua, J.-C.,
Poppers, D. M.,
Naime, D.,
Vilcek, J.,
and Cronstein, B. N.
(1996)
J. Immunol.
156,
1609-1615[Abstract]
|
| 4.
|
Enghild, J. J.,
Salvesen, G.,
Hefta, S. A.,
Thogersen, I. B.,
Rutherfurd, S.,
and Pizzo, S. V.
(1991)
J. Biol. Chem.
266,
747-751[Abstract/Free Full Text]
|
| 5.
|
Zhuo, L.,
Yoneda, M.,
Zhao, M.,
Yingsung, W.,
Yoshida, N.,
Kitagawa, Y.,
Kawamura, K.,
Suzuki, T.,
and Kimata, K.
(2001)
J. Biol. Chem.
276,
7693-7696[Abstract/Free Full Text]
|
| 6.
|
Blom, A.,
Pertoft, H.,
and Fries, E.
(1995)
J. Biol. Chem.
270,
9698-9701[Abstract/Free Full Text]
|
| 7.
|
Huang, L.,
Yoneda, M.,
and Kimata, K.
(1993)
J. Biol. Chem.
268,
26725-26730[Abstract/Free Full Text]
|
| 8.
|
Hutadilok, N.,
Ghosh, P.,
and Brooks, P. M.
(1988)
Ann. Rheum. Dis.
47,
377-385[Abstract/Free Full Text]
|
| 9.
|
Vetr, H.,
and Gebhard, W.
(1990)
Biol. Chem. Hoppe-Seyler
371,
1185-1196[Medline]
[Order article via Infotrieve]
|
| 10.
|
Lindqvist, A.,
Bratt, T.,
Altieri, M.,
Kastern, W.,
and Åkerström, B.
(1992)
Biochim. Biophys. Acta
1130,
63-67[Medline]
[Order article via Infotrieve]
|
| 11.
|
Sjöberg, E. M.,
and Fries, E.
(1992)
Arch. Biochem. Biophys.
295,
217-222[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Bratt, T.,
Olsson, H.,
Sjöberg, E. M.,
Jergil, B.,
and Åkerström, B.
(1993)
Biochim. Biophys. Acta
1157,
147-154[Medline]
[Order article via Infotrieve]
|
| 13.
|
Gebhard, W.,
Schreitmuller, T.,
Hochstrasser, K.,
and Wachter, E.
(1989)
Eur. J. Biochem.
181,
571-576[Medline]
[Order article via Infotrieve]
|
| 14.
|
Thøgersen, I. B.,
and Enghild, J. J.
(1995)
J. Biol. Chem.
270,
18700-18709[Abstract/Free Full Text]
|
| 15.
|
Morelle, W.,
Capon, C.,
Balduyck, M.,
Sautiere, P.,
Kouach, M.,
Michalski, C.,
Fournet, B.,
and Mizon, J.
(1994)
Eur. J. Biochem.
221,
881-888[Medline]
[Order article via Infotrieve]
|
| 16.
|
Blom, A. M.,
Thuveson, M.,
and Fries, E.
(1997)
Biochem. J.
328,
185-191
|
| 17.
|
Thuveson, M.,
and Fries, E.
(1999)
J. Biol. Chem.
274,
6741-6746[Abstract/Free Full Text]
|
| 18.
|
Thuveson, M.,
and Fries, E.
(2000)
J. Biol. Chem.
275,
30996-31000[Abstract/Free Full Text]
|
| 19.
|
Fosang, A. J.,
and Hardingham, T. E.
(1996)
in
Extracellular Matrix
(Comper, W. D., ed), Vol. 2
, pp. 200-229, Overseas Publishers Association, Amsterdam, The Netherlands
|
| 20.
|
Schwartz, N. B.,
Galligani, L., Ho, P. L.,
and Dorfman, A.
(1974)
Proc. Natl. Acad. Sci. U. S. A.
71,
4047-4051[Abstract/Free Full Text]
|
| 21.
|
Daveau, M.,
Jean, L.,
Soury, E.,
Olivier, E.,
Masson, S.,
Lyoumi, S.,
Chan, P.,
Hiron, M.,
Lebreton, J. P.,
Husson, A.,
Jegou, S.,
Vaudry, H.,
and Salier, J. P.
(1998)
Arch. Biochem. Biophys.
350,
315-323[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Salier, J. P.,
Chan, P.,
Raguenez, G.,
Zwingman, T.,
and Erickson, R. P.
(1993)
Biochem. J.
296,
85-91
|
| 23.
|
Sjöberg, E. M.,
and Fries, E.
(1990)
Biochem. J.
272,
113-118[Medline]
[Order article via Infotrieve]
|
| 24.
|
Peters, T., Jr.,
and Davidson, L. K.
(1982)
J. Biol. Chem.
257,
8847-8853[Abstract/Free Full Text]
|
| 25.
|
Sugio, S.,
Kashima, A.,
Mochizuki, S.,
Noda, M.,
and Kobayashi, K.
(1999)
Protein Eng.
12,
439-446[Abstract/Free Full Text]
|
| 26.
|
Simkin, P. A.,
and Bassett, J. E.
(1992)
J. Rheumatol.
19,
1017-1019[Medline]
[Order article via Infotrieve]
|
| 27.
|
Chan, P.,
Risler, J. L.,
Raguenez, G.,
and Salier, J. P.
(1995)
Biochem. J.
306,
505-512
|
| 28.
|
Martin-Vandelet, N.,
Paris, S.,
Bourguignon, J.,
Sesboue, R.,
Martin, J. P.,
and Diarra-Mehrpour, M.
(1999)
Eur. J. Biochem.
259,
476-484[Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. B. Wicher and E. Fries
Prohaptoglobin is proteolytically cleaved in the endoplasmic reticulum by the complement C1r-like protein
PNAS,
October 5, 2004;
101(40):
14390 - 14395.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.